QQ客服 官方微博 反馈留言

	The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression
	Sun, Cheng-Cao; Li, Shu-Jun; Zhang, Feng; Zhang, Ya-Dong; Zuo, Zhen-Yu; Xi, Yong-Yong; Wang, Liang; Li, De-Jia
刊名	MOLECULAR THERAPY-NUCLEIC ACIDS
	2016
卷号	5
关键词	drug resistance miR-9600 non-small-cell lung cancer STAT3 tumorigenesis
ISSN号	2162-2531
DOI	10.1038/mtna.2016.96
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4049040
专题	武汉大学
推荐引用方式 GB/T 7714	Sun, Cheng-Cao,Li, Shu-Jun,Zhang, Feng,et al. The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression[J]. MOLECULAR THERAPY-NUCLEIC ACIDS,2016,5.
APA	Sun, Cheng-Cao.,Li, Shu-Jun.,Zhang, Feng.,Zhang, Ya-Dong.,Zuo, Zhen-Yu.,...&Li, De-Jia.(2016).The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.MOLECULAR THERAPY-NUCLEIC ACIDS,5.
MLA	Sun, Cheng-Cao,et al."The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression".MOLECULAR THERAPY-NUCLEIC ACIDS 5(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。